Conatus Pharmaceuticals Quick Ratio 2012-2019 | CNAT

Historical quick ratio values for Conatus Pharmaceuticals (CNAT) over the last 10 years.
Conatus Pharmaceuticals Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-06-30 $0.00B $0.01B 0.00
2019-03-31 $0.00B $0.02B 0.00
2018-12-31 $0.00B $0.02B 0.00
2018-09-30 $0.00B $0.02B 0.00
2018-06-30 $0.00B $0.03B 0.00
2018-03-31 $0.00B $0.03B 0.00
2017-12-31 $0.00B $0.03B 0.00
2017-09-30 $0.00B $0.03B 0.00
2017-06-30 $0.00B $0.04B 0.00
2017-03-31 $0.00B $0.03B 0.00
2016-12-31 $0.00B $0.04B 0.00
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $0.00B $0.00B 0.00
2016-03-31 $0.00B $0.00B 0.00
2015-12-31 $0.00B $0.00B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.00B $0.00B 0.00
2014-09-30 $0.00B $0.00B 0.00
2014-06-30 $0.00B $0.00B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B $0.00B 0.00
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B $0.00B 0.00
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2011-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.011B $0.034B
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.323B 20.26
Abbott Laboratories (ABT) United States $141.074B 26.52
Stryker (SYK) United States $79.557B 27.51
Boston Scientific (BSX) United States $52.891B 25.66
Baxter (BAX) United States $44.520B 27.00
EssilorLuxottica Societe Anonyme (ESLOY) France $32.321B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.767B 17.77
Coloplast (CLPBY) Denmark $25.229B 40.28
Lonza Group Ag (LZAGY) Switzerland $24.768B 0.00
Terumo (TRUMY) Japan $23.431B 29.24
Smith & Nephew SNATS (SNN) United Kingdom $20.446B 0.00
ResMed (RMD) United States $18.578B 35.40
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $9.880B 52.96
Insulet (PODD) United States $9.176B 543.75
Perrigo (PRGO) Ireland $7.218B 13.30
Hill-Rom Holdings (HRC) United States $6.641B 19.80
Canopy Growth (CGC) Canada $6.561B 0.00
Haemonetics (HAE) United States $6.400B 48.30
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.611B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.590B 0.00
Neogen (NEOG) United States $3.348B 56.02
NuVasive (NUVA) United States $3.295B 26.27
ICU Medical (ICUI) United States $3.139B 20.36
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.427B 0.00
Quidel (QDEL) United States $2.414B 23.97
Agios Pharmaceuticals (AGIO) United States $1.901B 0.00
National Vision Holdings (EYE) United States $1.871B 40.39
Cardiovascular Systems (CSII) United States $1.582B 0.00
Aphria (APHA) $1.099B 0.00
VAREX IMAGING (VREX) United States $1.093B 25.19
AtriCure (ATRC) United States $0.999B 0.00
Phibro Animal Health (PAHC) United States $0.870B 14.15
Eagle Pharmaceuticals (EGRX) United States $0.830B 21.16
NanoString Technologies (NSTG) United States $0.769B 0.00
PetIQ (PETQ) United States $0.746B 17.62
Omeros (OMER) United States $0.734B 0.00
Lantheus Holdings (LNTH) United States $0.731B 19.21
LeMaitre Vascular (LMAT) United States $0.643B 38.13
Cerus (CERS) United States $0.603B 0.00
Surmodics (SRDX) United States $0.581B 110.51
Quanterix (QTRX) United States $0.554B 0.00
MacroGenics (MGNX) United States $0.550B 0.00
TG Therapeutics (TGTX) United States $0.494B 0.00
OraSure Technologies (OSUR) United States $0.481B 22.27
Meridian Bioscience (VIVO) United States $0.404B 12.60
Owens & Minor (OMI) United States $0.392B 11.74
Zynex (ZYXI) United States $0.374B 39.69
Utah Medical Products (UTMD) United States $0.342B 25.03
BioLife Solutions (BLFS) United States $0.329B 101.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.308B 0.00
United Health Products (UEEC) United States $0.240B 0.00
Bovie Medical (APYX) United States $0.230B 0.00
Vapotherm (VAPO) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.143B 0.00
Female Health (VERU) United States $0.135B 0.00
Fonar (FONR) United States $0.127B 8.94
InfuSystems Holdings (INFU) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.098B 0.00
Chimerix (CMRX) United States $0.095B 0.00
United-Guardian (UG) United States $0.086B 20.43
Nephros (NEPH) United States $0.074B 0.00
MTech Acquisition (KERN) United States $0.060B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.035B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.021B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Myomo (MYO) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00